Rivaroxaban Versus Warfarin and Risk of Post-Thrombotic Syndrome Among Patients with Venous Thromboembolism

Autor: Søgaard, Mette ^*, Nielsen, Peter Brønnum, Skjøth, Flemming, Kjældgaard, Jette Nordstrøm, Coleman, Craig I., Larsen, Torben Bjerregaard

Publikováno v: In The American Journal of Medicine July 2018 131(7):787-794

The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants

Autor: Lip, Gregory Y.H. ^*, Skjøth, Flemming, Nielsen, Peter Brønnum, Kjældgaard, Jette Nordstrøm, Larsen, Torben Bjerregaard

Publikováno v: In The American Journal of Medicine May 2018 131(5):574-574

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Framework for the Evaluation of the Effectiveness of Risk Minimisation Measures Applied to Retrospective Danish Real-World Dabigatran Etexilate Data

Autor: Nyeland, Martin Erik, Skjoth, Flemming, Nielsen, Peter Brønnum, Kjældgaard, Jette, Larsen, Torben Bjerregaard, Laursen, Mona Vestergaard, Callreus, Torbjörn

Publikováno v: Nyeland, M E, Skjoth, F, Nielsen, P B, Kjældgaard, J, Larsen, T B, Laursen, M V & Callreus, T 2016, ' A Framework for the Evaluation of the Effectiveness of Risk Minimisation Measures Applied to Retrospective Danish Real-World Dabigatran Etexilate Data ', Pharmacoepidemiology and Drug Safety, vol. 25, no. Suppl 3, 523, pp. 306 . < http://onlinelibrary.wiley.com/doi/10.1002/pds.v25.S3/issuetoc >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d9b60729cc1724ccf783c3dcdb1fbbf0
https://vbn.aau.dk/da/publications/7b452cde-c239-4337-916d-7a0f812066fc

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.